Literature DB >> 20818602

The expression of stem cell-related indicators as a prognostic factor in human lung adenocarcinoma.

Xue-Yan Zhang1, Qiang-Gang Dong, Jin-Su Huang, Ai-Mi Huang, Chun-Lei Shi, Bo Jin, Hui-Fang Sha, Jiu-Xian Feng, Qin Geng, Jin Zhou, Hui-Li Xu, Bao-hui Han.   

Abstract

INTRODUCTION: The purpose of the present study was to detect the presence of BASC-like stem cell-related indicators, such as clara cell secretory protein (CCSP), Octamer-4 (OCT4) and Bmi-1, and evaluate their implications in the prognosis of patients with lung adenocarcinoma.
METHODS: Specimens of 134 cases of lung adenocarcinoma were collected after radical surgery from January 1999 to June 2004.
RESULTS: One hundred and twenty-six cases showed cells that were positive for CCSP, 99 cases positive for OCT4, 91 cases simultaneous expression of CCSP and OCT4 and 74 cases positive for Bmi-1. Bmi-1 was significantly higher in patients at stage III compared to patients at stages I and II. The pattern of survival curves showed that Bmi-1 was a significant prognostic factor of poor overall survival in lung adenocarcinoma patients (P = 0.0000), and the patients with OCT4(+) expression showed a greater increase in mortality than OCT4(-) patients (P = 0.0103). The results of univariate and multivariate Cox analysis revealed that the pathological stages of tumor node metastases (P = 0.037), OCT4 (P = 0.046) and Bmi-1 expression (P = 0.001) were independent prognostic factors.
CONCLUSIONS: OCT4 and Bmi-1 may be good biomarkers to predict the prognosis of patients with completely resected lung adenocarcinoma. 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20818602     DOI: 10.1002/jso.21718

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

Review 1.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

2.  IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance.

Authors:  Xueyan Zhang; Jiayuan Sun; Huimin Wang; Yuqing Lou; Yanwei Zhang; Huifang Sha; Jiuxian Feng; Baohui Han
Journal:  Tumour Biol       Date:  2013-08-29

3.  Prognostication of OCT4 isoform expression in prostate cancer.

Authors:  Marina França de Resende; Ludmilla Thomé Domingos Chinen; Samantha Vieira; Juliano Jampietro; Francisco Paulo da Fonseca; José Vassallo; Luciene Cristina Campos; Gustavo Cardoso Guimarães; Fernando Augusto Soares; Rafael Malagoli Rocha
Journal:  Tumour Biol       Date:  2013-05-01

Review 4.  Cellular reprogramming and hepatocellular carcinoma development.

Authors:  Yun-Wen Zheng; Yun-Zhong Nie; Hideki Taniguchi
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

Review 5.  Pluripotency transcription factors in lung cancer-a review.

Authors:  Sylwia Sławek; Krzysztof Szmyt; Maciej Fularz; Joanna Dziudzia; Maciej Boruczkowski; Jan Sikora; Mariusz Kaczmarek
Journal:  Tumour Biol       Date:  2015-11-18

6.  OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma.

Authors:  Lu Cao; Chunguang Li; Shuwen Shen; Yan Yan; Weidan Ji; Jinghan Wang; Haihua Qian; Xiaoqing Jiang; Zhigang Li; Mengchao Wu; Ying Zhang; Changqing Su
Journal:  BMC Cancer       Date:  2013-02-22       Impact factor: 4.430

7.  Expression and survival significance of B-cell-specific Moloney murine leukemia virus integration site 1 and matrix metalloproteinase-9 in non-small-cell lung cancer.

Authors:  Mingkui Mu; Yang Song; Bin Zhang
Journal:  Oncol Lett       Date:  2016-09-29       Impact factor: 2.967

8.  Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel prognostic markers for non-small-cell lung cancer progression and patients' overall survival.

Authors:  B-H Kuang; M-Q Zhang; L-H Xu; L-J Hu; H-B Wang; W-F Zhao; Y Du; X Zhang
Journal:  Br J Cancer       Date:  2013-08-06       Impact factor: 7.640

9.  Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.

Authors:  Xiaoyan Zhao; Hui Lu; Yan Sun; Li Liu; Huafang Wang
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.